Skip to content

MLTX · MoonLake Immunotherapeutics

Healthcare · −6.9% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 4 days, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive MLTX chart (by TradingView) loads here.

Our take

3 rules fired on MLTX

In short: none of these rules has solid or some evidence yet, so they show no clear lean on MLTX.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for MLTX, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on MLTX, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of MLTX. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 23, 2026–Oct 20, 2026 · UTC dates · today is excluded

Insider purchases

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 22, 2025Oct 20, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 17, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 20260Partial; excluded
Jul 1, 2026–Jul 28, 20260Within stored history
Jul 29, 2026–Aug 25, 20260Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 1; range: 0–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 20262Partial; excluded
Jul 1, 2026–Jul 28, 20262Within stored history
Jul 29, 2026–Aug 25, 20261Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

Owners & lobbying

Company filings · Sep 2026

  1. Filed
All 29 records in this snapshot
  1. Filed
  2. Record date
  3. Record date
  4. Filed
  5. Record date
  6. Filed
  7. Filed
  8. Filed
  9. Disclosed
    Kristian Reich · Sale

    Transaction dated Jul 27, 2026

  10. Disclosed
    Kristian Reich · Sale

    Transaction dated Jul 21, 2026

  11. Disclosed
    Kristian Reich · Sale

    Transaction dated Jul 22, 2026

  12. Disclosed
    Kristian Reich · Sale

    Transaction dated Jul 20, 2026

  13. Disclosed
    Kristian Reich · Sale

    Transaction dated Jul 15, 2026

  14. Filed
  15. Filed
  16. Disclosed
    da Silva Jorge Santos · Sale

    Transaction dated Jul 10, 2026

  17. Disclosed
    da Silva Jorge Santos · Sale

    Transaction dated Jul 9, 2026

  18. Disclosed
    da Silva Jorge Santos · Sale

    Transaction dated Jul 1, 2026

  19. Filed
  20. Filed
  21. Record date
    FDA warning letter ↗

    8-K · mentioned before

  22. Disclosed
    Matthias Bodenstedt · Sale

    Transaction dated Jun 22, 2026

  23. Disclosed
    Matthias Bodenstedt · Sale

    Transaction dated Jun 18, 2026

  24. Disclosed
    Matthias Bodenstedt · Sale

    Transaction dated Jun 17, 2026

  25. Disclosed
    Kristian Reich · Sale

    Transaction dated Jun 15, 2026

  26. Disclosed
    Kristian Reich · Sale

    Transaction dated Jun 16, 2026

  27. Disclosed
    Kristian Reich · Sale

    Transaction dated Jun 17, 2026

  28. Filed
  29. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on MLTX disclosed in the last 90 days.

See every Congress trade on MLTX →

Company insiders

0 buys · 4 sells (5 filed lots) · $2.3M sold

  1. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$22Kdisclosed Jul 29 · filed 2 days after the trade
  2. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$1Mdisclosed Jul 23 · filed 2 days after the trade
  3. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$49Kdisclosed Jul 23 · filed 1 day after the trade
  4. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$878Kdisclosed Jul 21 · filed 1 day after the trade
  5. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$322Kdisclosed Jul 20 · filed 5 days after the trade · late
See every insider trade on MLTX →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: T. Rowe Price Investment Management, Inc. (13G), Aug 14, 2026 ↗

Filings & events

Company filings (8-K) 61

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Shared information with investors · item 7.0111
  • Quarterly or yearly results · item 2.0210
  • Other events · item 8.019
  • Signed a major agreement · item 1.015
  • Directors or officers joined, left or got new pay · item 5.024
  • Shareholder vote results · item 5.073

Filing red flags 18

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 11

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

None in the last 90 days · 11 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 8

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 3 filings
  • 13G, just holds: 5 filings

Filed most: Biotechnology Value Fund L P (3) · T. Rowe Price Investment Management, Inc. (1) · Cormorant Asset Management, LP (1) · Deep Track Capital, LP (1)

Biggest named funds (13F)

The largest MLTX holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on MLTX

  1. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$22Kdisclosed Jul 29 · filed 2 days after the trade
  2. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$1Mdisclosed Jul 23 · filed 2 days after the trade
  3. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$49Kdisclosed Jul 23 · filed 1 day after the trade
  4. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$878Kdisclosed Jul 21 · filed 1 day after the trade
  5. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$322Kdisclosed Jul 20 · filed 5 days after the trade · late
  6. ▼ SELLda Silva Jorge Santos Chief Executive OfficerMLTX MoonLake Immunotherapeutics$1.4Mdisclosed Jul 13 · filed 3 days after the trade
  7. ▼ SELLda Silva Jorge Santos Chief Executive OfficerMLTX MoonLake Immunotherapeutics$679Kdisclosed Jul 13 · filed 4 days after the trade
  8. ▼ SELLda Silva Jorge Santos Chief Executive OfficerMLTX MoonLake Immunotherapeutics$957Kdisclosed Jul 2 · filed 1 day after the trade
  9. ▼ SELLMatthias Bodenstedt Chief Financial OfficerMLTX MoonLake Immunotherapeutics$862Kdisclosed Jun 23 · filed 1 day after the trade
  10. ▼ SELLMatthias Bodenstedt Chief Financial OfficerMLTX MoonLake Immunotherapeutics$54.8Kdisclosed Jun 18 · filed the same day
  11. ▼ SELLMatthias Bodenstedt Chief Financial OfficerMLTX MoonLake Immunotherapeutics$297Kdisclosed Jun 18 · filed 1 day after the trade
  12. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$945Kdisclosed Jun 17 · filed 2 days after the trade
  13. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$935Kdisclosed Jun 17 · filed 1 day after the trade
  14. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$972Kdisclosed Jun 17 · filed the same day
See the trades on MLTX in the feed →
People & votes

Which members of Congress traded MLTX, sponsored bills that touch it and voted on them — opens here.